Analysts' recommendations: Carmat SA

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
09/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

03-04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
01-07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
01-07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
01-07	CARMAT : A suivre aujourd'hui
01-07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	31/08/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	11/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	31/03/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	01/01/2017
Michael Mack BRD	Director/Board Member	79	19/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris Other stock markets 16:55:00 19/03/2026 GMT			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Market Cap	6.15M 6.99M 5.74M 5.26M 9.86M 670M 10.1M 68.03M 26.6M 332M 26.26M 25.69M 1.15B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.42M 55.3M 50.75M 95M 6.46B 97.35M 656M 256M 3.2B 253M 248M 11.05B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
01-07	CARMAT: To Watch Today
01-06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
01-06	Carmat Announces Liquidation and Delisting
12-02	Only Takeover Bid for Carmat Approved by Court
12-02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
12-02	Carmat receives takeover bid	RE
11-04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

12-02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
11-04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Current year	0.1	0.1
1 year	0.08	0.59
3 years	0.08	9.99
5 years	0.08	31.7
10 years	0.08	44.95

Carmat SA Share Price

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news : Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Course Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/03/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
13/03/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
29/05/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-68.47%	-98.69%	7.08M
STRYKER CORPORATION	+1.20%	+13.33%	-12.51%	+23.66%	133B
SMITH & NEPHEW PLC	+1.21%	+8.53%	+2.92%	+2.49%	13.43B
GLAUKOS CORPORATION	+3.94%	+2.38%	+66.92%	+102.88%	8.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.27%	+4.27%	-44.88%	-69.82%	4.71B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.18%	+0.25%	+0.54%	+38.53%	2.63B
ENOVIS CORPORATION	+1.29%	+12.73%	+9.55%	-53.16%	1.7B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.47%	+1.44%	-15.85%	-23.38%	1.62B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.35%	+3.25%	-24.63%	-33.29%	1.61B
Average	+1.59%	+2.79%	-9.60%	-12.31%	18.61B
Weighted average by Cap.	+1.26%	+4.99%	-7.69%	+21.99%

	2023	2024
Net sales	3.84M 4.37M 3.58M 3.29M 6.15M 418M 6.3M 42.47M 16.61M 207M 16.39M 16.04M 715M	7.34M 8.36M 6.86M 6.29M 11.78M 801M 12.07M 81.29M 31.79M 396M 31.38M 30.7M 1.37B
Net income	-53.87M -61.31M -50.28M -46.15M -86.38M -5.87B -88.51M -596M -233M -2.91B -230M -225M -10.05B	-51.4M -58.49M -47.97M -44.03M -82.42M -5.6B -84.45M -569M -222M -2.77B -220M -215M -9.58B
Net Debt	49.64M 56.49M 46.33M 42.52M 79.59M 5.41B 81.56M 549M 215M 2.68B 212M 207M 9.26B	53.1M 60.43M 49.56M 45.49M 85.15M 5.79B 87.25M 588M 230M 2.86B 227M 222M 9.9B